Dr. Mack, the first surgeon to receive the award, has made significant contributions to research involving minimally invasive surgery and percutaneous heart valve therapy. He has performed over 7,000 cardiac surgeries, including 3,000 heart valve procedures.
Researchers developed a methodology for describing dynamic sugar chain behaviors at atomic resolution, enabling the characterization of minor but biologically relevant conformational species. This breakthrough opens doors to observing flexible biomolecules as potential drug targets.
A new electroencephalography (EEG) tool has been developed to detect refractory idiopathic epilepsy in children, a condition that cannot be managed by antiepileptic drugs. The tool uses EEG classification analysis and identifies significant EEG features that distinguish refractory epilepsy from well-controlled forms.
Researchers at Wake Forest Baptist Medical Center developed a new method to coat blood vessels in lab-grown kidneys, allowing them to remain open for four hours. The breakthrough could potentially be applied to other complex organs, such as the liver and pancreas.